105 related articles for article (PubMed ID: 27506920)
1. A novel canine B-cell leukaemia cell line. Establishment, characterisation and sensitivity to chemotherapeutics.
Pawlak A; Ziolo E; Kutkowska J; Blazejczyk A; Wietrzyk J; Krupa A; Hildebrand W; Dziegiel P; Dzimira S; Obminska-Mrukowicz B; Strzadala L; Rapak A
Vet Comp Oncol; 2017 Dec; 15(4):1218-1231. PubMed ID: 27506920
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of a novel canine B-cell line derived from a spontaneously occurring diffuse large cell lymphoma.
Rütgen BC; Hammer SE; Gerner W; Christian M; de Arespacochaga AG; Willmann M; Kleiter M; Schwendenwein I; Saalmüller A
Leuk Res; 2010 Jul; 34(7):932-8. PubMed ID: 20153049
[TBL] [Abstract][Full Text] [Related]
3. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative effects of masitinib and imatinib against canine oral fibrosarcoma in vitro.
Milovancev M; Helfand SC; Marley K; Goodall CP; Löhr CV; Bracha S
BMC Vet Res; 2016 Jun; 12():85. PubMed ID: 27259510
[TBL] [Abstract][Full Text] [Related]
5. A novel canine lymphoma cell line: a translational and comparative model for lymphoma research.
Kisseberth WC; Nadella MV; Breen M; Thomas R; Duke SE; Murahari S; Kosarek CE; Vernau W; Avery AC; Burkhard MJ; Rosol TJ
Leuk Res; 2007 Dec; 31(12):1709-20. PubMed ID: 17532464
[TBL] [Abstract][Full Text] [Related]
6. Establishment and characterization of a new canine B-cell leukemia cell line.
Nakaichi M; Taura Y; Kanki M; Mamba K; Momoi Y; Tsujimoto H; Nakama S
J Vet Med Sci; 1996 May; 58(5):469-71. PubMed ID: 8741612
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effects of piroxicam in spontaneous canine invasive urinary bladder cancer, a relevant model of human invasive bladder cancer.
Knapp DW; Glickman NW; Mohammed SI; DeNicola DB; Widmer WR; Bonney PL; DeGortari AE
Adv Exp Med Biol; 2002; 507():377-80. PubMed ID: 12664613
[No Abstract] [Full Text] [Related]
8. 6-Thioguanine and zebularine down-regulate DNMT1 and globally demethylate canine malignant lymphoid cells.
Flesner BK; Kumar SR; Bryan JN
BMC Vet Res; 2014 Dec; 10():290. PubMed ID: 25480665
[TBL] [Abstract][Full Text] [Related]
9. Gaining insights into the Bcr-Abl activity-independent mechanisms of resistance to imatinib mesylate in KCL22 cells: a comparative proteomic approach.
Colavita I; Esposito N; Martinelli R; Catanzano F; Melo JV; Pane F; Ruoppolo M; Salvatore F
Biochim Biophys Acta; 2010 Oct; 1804(10):1974-87. PubMed ID: 20417730
[TBL] [Abstract][Full Text] [Related]
10. Intranuclear inclusions in a dog with B-cell leukemia.
Kato D; Takahashi M; Harada T; Tsuboi M; Uchida K; Fukushima K; Kanemoto H; Fujino Y; Ohno K; Nakayama H; Tsujimoto H
Vet Clin Pathol; 2016 Dec; 45(4):579-583. PubMed ID: 27787912
[TBL] [Abstract][Full Text] [Related]
11. Heterotransplantation of canine sarcoma cells (BLU284) in athymic (nude) mice.
Aaronson LM; Pardini LL; Pardini RS
Am J Vet Res; 1987 May; 48(5):816-21. PubMed ID: 3592383
[TBL] [Abstract][Full Text] [Related]
12. ZAP-70 and Syk expression in canine lymphoid cells and preliminary results on leukaemia cases.
Mortarino M; Gelain ME; Gioia G; Ciusani E; Bazzocchi C; Comazzi S
Vet Immunol Immunopathol; 2009 Apr; 128(4):395-401. PubMed ID: 19144411
[TBL] [Abstract][Full Text] [Related]
13. Complex of Platinum(II) with Tris(2-carboxyethyl)phosphine Induces Apoptosis in Canine Lymphoma/Leukemia Cell Lines.
Henklewska M; Pawlak A; Pruchnik H; Obminska-Mrukowicz B
Anticancer Res; 2017 Feb; 37(2):539-546. PubMed ID: 28179299
[TBL] [Abstract][Full Text] [Related]
14. The in vitro effects of piroxicam and meloxicam on canine cell lines.
Knottenbelt C; Chambers G; Gault E; Argyle DJ
J Small Anim Pract; 2006 Jan; 47(1):14-20. PubMed ID: 16417605
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of tyrosine kinases and use of imatinib in small animal practice.
Bonkobara M
Vet J; 2015 Aug; 205(2):180-8. PubMed ID: 25592261
[TBL] [Abstract][Full Text] [Related]
16. Selective and effective targeting of chronic myeloid leukemia stem cells by topoisomerase II inhibitor etoposide in combination with imatinib mesylate in vitro.
Liu MY; Wang WZ; Liao FF; Wu QQ; Lin XH; Chen YH; Cheng L; Jin XB; Zhu JY
Cell Biol Int; 2017 Jan; 41(1):16-23. PubMed ID: 27677634
[TBL] [Abstract][Full Text] [Related]
17. Blastic natural killer cell leukaemia in a dog--a case report.
Bonkobara M; Saito T; Yamashita M; Tamura K; Yagihara H; Isotani M; Sato T; Washizu T
Vet J; 2007 Nov; 174(3):659-62. PubMed ID: 17113799
[TBL] [Abstract][Full Text] [Related]
18. Establishment of a novel feline leukemia virus (FeLV)-negative B-cell cell line from a cat with B-cell lymphoma.
Mochizuki H; Takahashi M; Nishigaki K; Ide T; Goto-Koshino Y; Watanabe S; Sato H; Sato M; Kotera Y; Fujino Y; Ohno K; Uchida K; Tsujimoto H
Vet Immunol Immunopathol; 2011 Apr; 140(3-4):307-11. PubMed ID: 21272942
[TBL] [Abstract][Full Text] [Related]
19. Establishment and Characterization of PCL12, a Novel CD5+ Chronic Lymphocytic Leukaemia Cell Line.
Agathangelidis A; Scarfò L; Barbaglio F; Apollonio B; Bertilaccio MT; Ranghetti P; Ponzoni M; Leone G; De Pascali V; Pecciarini L; Ghia P; Caligaris-Cappio F; Scielzo C
PLoS One; 2015; 10(6):e0130195. PubMed ID: 26110819
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the drug sensitivity and expression of 16 drug resistance-related genes in canine histiocytic sarcoma cell lines.
Asada H; Tomiyasu H; Goto-Koshino Y; Fujino Y; Ohno K; Tsujimoto H
J Vet Med Sci; 2015 Jun; 77(6):677-84. PubMed ID: 25715778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
